SCHEMBL28840697

SCHEMBL28840697

O=C(O)Cc1ccc2c(c1)C1(CCO2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 2/20 0.51
CYP26B1 Q9NR63 1/20 0.51
AKR1B1 P15121 2/20 0.46
CA2 P00918 1/20 0.41
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
RGS12 O14924 1/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40
APEX1 P27695 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30148890 0.93 CYP26A1 (0.48) CYP26A1CYP26B1AKR1B1CA2RAB9A
SCHEMBL28953081 0.88 CYP26A1 (0.46) CYP26A1CYP26B1AKR1B1CA2RAB9A
SCHEMBL6146899 0.84 CYP26A1 (0.69) CYP26A1CYP26B1AKR1B1RXRARXRB
SCHEMBL6146444 0.81 CYP26A1 (0.50) CYP26A1CYP26B1AKR1B1CA2RAB9A
SCHEMBL1162271 0.81 CYP26A1 (0.50) CYP26A1CYP26B1AKR1B1CA2RAB9A
SCHEMBL28347731 0.77 RARA (0.54) CYP26A1CYP26B1AKR1B1CA2RAB9A
SCHEMBL30353220 0.77 RARA (0.54) CYP26A1CYP26B1AKR1B1CA2RAB9A
SCHEMBL286952 0.76 ALDH1A1 (0.60) AKR1B1RAB9AALDH1A1HPGDHSD17B10
SCHEMBL28922878 0.75 PDCD1 (0.36) CYP26A1CYP26B1AKR1B1ALDH1A1LMNA
SCHEMBL17316518 0.75 CYP26A1 (0.52) CYP26A1CYP26B1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114907389-A Boronic acid derivatives 首药控股(北京)股份有限公司 2022-08-16 CN disclosed